Investor Presentation Q1-Q3 2020

Investor presentation First nine months of 2020 STRENGTHEN LEADERSHIP by offering innovative medicines and driving patient outcomes 1. Disease and market 2. Insulin segment 3. GLP-1 segment novo nordisk 33 41 44 Diabetes care YASMIN FIEDLER Yasmin has type 1 diabetes Germany

View entire presentation